Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?

The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, represents a potentially major challenge to patients with immune-mediated inflammatory diseases who are treated with immunomodulatory therapies. We report the case of an 18-year-old u...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdullah, Abdullah, Neurath, Markus F., Atreya, Raja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger GmbH 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316657/
https://www.ncbi.nlm.nih.gov/pubmed/32999889
http://dx.doi.org/10.1159/000508740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316657/
https://www.ncbi.nlm.nih.gov/pubmed/32999889
http://dx.doi.org/10.1159/000508740

Ejemplares similares